0

543434

SUPRIYA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SUPRIYA LIFESCIENCE LTD Share Price Today

Supriya Lifescience Limited is currently trading at ₹948.3, down by ₹3.85 from the previous close. The stock touched an intraday high of ₹983.95 and a low of ₹940.30 during the latest trading session. Over the past one year, Supriya Lifescience Limited has delivered a return of 35.99%, while the stock has gained 37.55% in the last one month.

Investment Returns

Over 1 Month 37.55% Over 3 Months 53.73% Over 6 Months 27.82% Over 1 Year 35.99%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SUPRIYA LIFESCIENCE LTD fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 7,639.80
  • P/E Ratio (TTM) 36.65
  • Beta 0.71
  • Book Value / share 148.81
  • Return on equity 20.74%
  • EPS (TTM) 26.03
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 74.23
info icon alternate text

SUPRIYA LIFESCIENCE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 276.53
Operating Expense 187.88
Net Profit 74.23
Net Profit Margin (%) 26.84
Earnings Per Share (EPS) 9.22
EBITDA 101.10
Effective Tax Rate (%) 19.42
Particulars DEC 2025 (Values in Cr)
Revenue 206.44
Operating Expense 141.67
Net Profit 49.68
Net Profit Margin (%) 24.06
Earnings Per Share (EPS) 6.17
EBITDA 74.22
Effective Tax Rate (%) 25.77
Particulars SEP 2025 (Values in Cr)
Revenue 199.83
Operating Expense 134.25
Net Profit 50.43
Net Profit Margin (%) 25.23
Earnings Per Share (EPS) 6.27
EBITDA 75.38
Effective Tax Rate (%) 26.18
Particulars JUN 2025 (Values in Cr)
Revenue 145.07
Operating Expense 100.33
Net Profit 34.79
Net Profit Margin (%) 23.98
Earnings Per Share (EPS) 4.32
EBITDA 54.37
Effective Tax Rate (%) 26.61
Particulars MAR 2025 (Values in Cr)
Revenue 184.11
Operating Expense 123.03
Net Profit 50.38
Net Profit Margin (%) 27.36
Earnings Per Share (EPS) 6.29
EBITDA 70.56
Effective Tax Rate (%) 21.35
Particulars MAR 2026 (Values in Cr)
Revenue 827.88
Operating Expense 564.13
Net Profit 209.12
Net Profit Margin (%) 25.25
Earnings Per Share (EPS) 25.98
EBITDA 305.08
Effective Tax Rate (%) 23.89
Particulars MAR 2025 (Values in Cr)
Revenue 696.49
Operating Expense 457.82
Net Profit 187.96
Net Profit Margin (%) 26.98
Earnings Per Share (EPS) 23.35
EBITDA 270.61
Effective Tax Rate (%) 24.35
Particulars MAR 2024 (Values in Cr)
Revenue 570.37
Operating Expense 415.32
Net Profit 119.11
Net Profit Margin (%) 20.88
Earnings Per Share (EPS) 14.80
EBITDA 183.61
Effective Tax Rate (%) 28.11
Particulars MAR 2023 (Values in Cr)
Revenue 460.94
Operating Expense 346.94
Net Profit 89.86
Net Profit Margin (%) 19.49
Earnings Per Share (EPS) 11.16
EBITDA 138.39
Effective Tax Rate (%) 27.23
Particulars MAR 2022 (Values in Cr)
Revenue 530.05
Operating Expense 330.38
Net Profit 151.81
Net Profit Margin (%) 28.64
Earnings Per Share (EPS) 18.86
EBITDA 221.57
Effective Tax Rate (%) 26.75
Particulars MAR 2025 (Values in Cr)
Book Value / Share 123.84
ROE % 20.74
ROCE % 27.43
Total Debt to Total Equity 0.01
EBITDA Margin 34.62
Particulars MAR 2024 (Values in Cr)
Book Value / Share 101.31
ROE % 15.73
ROCE % 22.05
Total Debt to Total Equity 0.02
EBITDA Margin 28.85
Particulars MAR 2023 (Values in Cr)
Book Value / Share 86.91
ROE % 13.67
ROCE % 18.43
Total Debt to Total Equity 0.04
EBITDA Margin 26.79
Particulars MAR 2022 (Values in Cr)
Book Value / Share 76.50
ROE % 34.34
ROCE % 41.97
Total Debt to Total Equity 0.11
EBITDA Margin 37.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 36.70
ROE % 59.18
ROCE % 55.75
Total Debt to Total Equity 0.37
EBITDA Margin 41.34
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 79.15
Total Assets 1112.31
Total Liabilities 1112.31
Total Equity 996.76
Share Outstanding 8
Price to Book Ratio 5.92
Return on Assets (%) 16.89
Return on Capital (%) 18.86
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 74.95
Total Assets 921.44
Total Liabilities 921.44
Total Equity 815.36
Share Outstanding 8
Price to Book Ratio 3.27
Return on Assets (%) 12.92
Return on Capital (%) 14.61
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 157.58
Total Assets 820.27
Total Liabilities 820.27
Total Equity 699.45
Share Outstanding 8
Price to Book Ratio 2.19
Return on Assets (%) 10.95
Return on Capital (%) 12.55
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 227.90
Total Assets 734.76
Total Liabilities 734.76
Total Equity 615.68
Share Outstanding 8
Price to Book Ratio 6.44
Return on Assets (%) 20.66
Return on Capital (%) 23.83
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 89.27
Total Assets 445.46
Total Liabilities 445.46
Total Equity 268.58
Share Outstanding 7
Price to Book Ratio 0.00
Return on Assets (%) 27.74
Return on Capital (%) 36.49
Particulars MAR 2025 (Values in Cr)
Net Income 248.48
Cash from Operations 223.85
Cash from Investing -152.24
Cash from Financing -8.23
Net change in Cash 4.19
Free Cash Flow 386.23
Particulars MAR 2024 (Values in Cr)
Net Income 165.69
Cash from Operations 150.95
Cash from Investing -173.57
Cash from Financing -22.35
Net change in Cash -82.62
Free Cash Flow 296.60
Particulars MAR 2023 (Values in Cr)
Net Income 123.48
Cash from Operations 94.28
Cash from Investing -123.65
Cash from Financing -10.27
Net change in Cash -70.32
Free Cash Flow 202.19
Particulars MAR 2022 (Values in Cr)
Net Income 207.24
Cash from Operations 109.76
Cash from Investing -59.82
Cash from Financing 149.65
Net change in Cash 138.63
Free Cash Flow 169.66
Particulars MAR 2021 (Values in Cr)
Net Income 167.30
Cash from Operations 105.88
Cash from Investing -46.80
Cash from Financing -14.51
Net change in Cash 14.57
Free Cash Flow 154.12
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 34.81 14.38 1.68 266.76 23.12 38.85
BLISS GVS PHARMA LTD 456.85 36.96 4.05 4832.97 118.35 462.70
CIPLA LTD. 1397.75 29.66 3.27 112910.32 1165.55 1672.20
FERMENTA BIOTECH LTD. 319.55 14.10 2.31 940.47 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2166.50 35.95 16.18 36701.82 2155.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 34.81 24.34 4.48 266.76 23.12 38.85
AMRUTAJAN HEALTH LTD 545.45 24.45 4.25 1576.93 490.00 789.95
ASTRAZENECA PHARMA IND LT 8497.05 110.97 24.33 21242.63 7630.00 10653.05
BLISS GVS PHARMA LTD 456.85 49.12 4.18 4832.97 118.35 462.70

SUPRIYA LIFESCIENCE LTD shareholding pattern

Holding
20.84%
68.29%
5.15%
5.7%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

SUPRIYA LIFESCIENCE LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
949.25 -0.30 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 922.30
  • 26 Days 788.40
  • 10 Days 877.00
  • 50 Days 735.50
  • 12 Days 861.10
  • 100 Days 707.80
  • 20 Days 812.90
  • 200 Days 695.70
935.67 PIVOT
First Support 913.38 First Resistance 974.43 Second Support 874.62 Second Resistance 996.72 Third Support 852.33 Third Resistance 1035.48
RSI 67.84 ADX 52.04 MACD 72.74 Williams % R -31.77 Commodity Channel Index (CCI) 118.61
Date 2026-06-04 Week 55066.00 Same Day 19497.00 Month 18017.00
1 Year 0.71 3 Year 1.03
Over 1 Month
37.55% down
Over 1 Year
35.99% down
Over 3 Months
53.73% down
Over 3 Years
55.50% down
Over 6 Months
27.82% down
Over 5 Years
19.52% down

SUPRIYA LIFESCIENCE LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
04 Sep 2025 1.0 Final 05 Sep 2025 Equity shares
20 Sep 2024 0.8 Final 21 Sep 2024 Equity shares
15 Sep 2023 0.6 Final 15 Sep 2023 Equity shares
01 Sep 2022 0.6 Final 02 Sep 2022 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Supriya Lifescience Ltd?

Answer Field

Supriya Lifescience Ltd share price is for NSE ₹ 947.95 & for BSE ₹ 949.25 as on Jun 05 2026 03:30 PM.

What is the Market Cap of Supriya Lifescience Ltd Share?

Answer Field

The market cap of Supriya Lifescience Ltd for NSE ₹ 0.00 & for BSE ₹ 7,639.80 as on Jun 05 2026 03:30 PM.

What is the 52 Week High and Low of Supriya Lifescience Ltd?

Answer Field

The 52 Week High and Low of Supriya Lifescience Ltd for NSE is ₹ 1,085.00 and ₹ 545.50 and for BSE is ₹ 1,085.50 and ₹ 545.65.

What is 1 year return for Supriya Lifescience Ltd?

Answer Field

The 1 year returns on the stock has been 35.99%.

What is the P/E Ratio of Supriya Lifescience Ltd Share?

Answer Field

As on Jun 05 2026 03:30 PM the price-to-earnings (PE) ratio for Supriya Lifescience Ltd share is 36.65.

What is the PB ratio of Supriya Lifescience Ltd Share?

Answer Field

As on Jun 05 2026 03:30 PM, the price-to-book (PB) ratio for Supriya Lifescience Ltd share is 148.81.

How to Buy Supriya Lifescience Ltd Share?

Answer Field

You can trade in Supriya Lifescience Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Supriya Lifescience Ltd Share on Bajaj Broking App?

Answer Field

To buy Supriya Lifescience Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Supriya Lifescience Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|